ArticleThe World Allergy Organization journal2026
Epidemiological shifts and temporal trends in emergency department anaphylaxis management: An 18-year longitudinal study in northern Thailand.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although anaphylaxis incidence is rising globally, long-term longitudinal data from Southeast Asia remain scarce. This study evaluates 18-year trends in anaphylaxis visit rates, etiological triggers, and clinical management in Northern Thailand, specifically assessing the impact of institutional protocols implemented in alignment with the 2017 Thai National Clinical Practice Guidelines for Anaphylaxis. Methods: We conducted an 8-year retrospective study (2017-2024) at a tertiary university hospital, integrating data with a previous 10-year cohort (2007-2016) under an identical clinical adjudication and exclusion protocol. Cases were identified via ICD-10 codes and manually adjudicated using 2006 NIAID-FAAN clinical criteria. We analyzed demographics, triggers, management metrics, and outcomes using multivariable logistic regression. Longitudinal trends adjusted for annual Emergency Department (ED) volumes were evaluated using a Poisson log-linear regression model with a log offset. Results: Among 647 anaphylaxis events (626 patients), the 2017-2024 presentation rate was 360.7/100,000 ED visits in children and 282.4/100,000 in adults. Adjusting for ED volume, Poisson regression revealed a compounding yearly rate increase of 10% in adults (IRR = 1.10, 95% CI: 1.09-1.12, Conclusions: Anaphylaxis ED visit rates demonstrated a significant longitudinal increase over 18 years, driven by the adult population and characterized by an evolving distribution of food triggers toward shellfish and edible insects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.